Opendata, web and dolomites

HEGEMONIC SIGNED

HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HEGEMONIC project word cloud

Explore the words cloud of the HEGEMONIC project. It provides you a very rough idea of what is the project "HEGEMONIC" about.

proportion    nearly    genomic    tumors    individuals    sizes    rare    identification    conventional    never    compare    genotype    somatic    wes    confer    reflect    genes    generation    phenotype    patients    ngs    performed    controls    uk10k    contributed    carcinoma    nevertheless    generate    host    advantage    small    liver    variation    integrative    uncovered    risk    carcinogenesis    coding    analyze    signals    cancers    effect    few    mutated    worldwide    captured    epi    350    replication    data    biological    ultimately    genome    validation    despite    susceptibility    associations    linked    hypothesizes    candidate    germline    reproducibly    gwas    suggesting    limited    biomarkers    death    extensive    association    compiled    sequencing    first    cohorts    landscape    pharmaceutical    genetic    normal    aggregation    thousands    hepatocellular    cells    hcc    detection    heritability    publicly    clinical    hegemonic    sources    recurrently    hypotheses    exome    regions    amount    variants    group    proposes    series    cancer    usually    combining    environmental   

Project "HEGEMONIC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE PARIS 

There are not information about this coordinator. Please contact Fabio for more information, thanks.

 Coordinator Country France [FR]
 Total cost 173˙076 €
 EC max contribution 173˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE PARIS FR (PARIS) coordinator 173˙076.00
2    UNIVERSITE PARIS DESCARTES FR (PARIS CEDEX 06) coordinator 0.00

Map

 Project objective

Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. Although several environmental factors have been identified, many affected individuals never develop HCC, suggesting a genetic susceptibility. Candidate genes and genome-wide association studies (GWAS) have only uncovered a few variants reproducibly linked to HCC. GWAS design typically allows the detection of common variants that usually have small effect sizes. Even taken together, they explain a very limited proportion of the heritability. This could reflect the presence of rare variants that may confer very large effect sizes. These may be captured by next-generation sequencing (NGS). Whole exome sequencing (WES) of thousands of tumors has defined the somatic genetic landscape of the most common cancers. Using WES, the host group has strongly contributed to the identification of the major pathways recurrently mutated in HCC. Nevertheless, despite the large amount of NGS data generated by cancer genome projects, the analysis of rare germline variants (i.e. variation pre-existing in normal cells) is currently a neglected field, particularly in liver carcinogenesis. The HEGEMONIC project hypothesizes that rare variants in coding regions of the genome (exome) impact the risk of HCC. This project proposes an integrative approach combining (epi)genomic information generated by the host group and from publicly available sources. First, the applicant will compare WES data from a series of 350 patients with HCC to nearly 70,000 controls compiled by the Exome Aggregation and UK10K consortia. Then, validation of the top signals will be performed by conventional sequencing in three replication cohorts. Finally, the applicant will analyze genotype-phenotype associations, taking advantage of the extensive clinical data available. Ultimately, the HEGEMONIC project may generate new biological hypotheses in liver carcinogenesis and identify new biomarkers and pharmaceutical targets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEGEMONIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEGEMONIC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EVOMET (2019)

The rise and fall of metastatic clones under immune attack

Read More  

ReSOLeS (2019)

New Reconfigurable Spectrum Optical Fibre Laser Sources

Read More  

ICARUS (2020)

Information Content of locAlisation: fRom classical to qUantum Systems

Read More